Ultrasis plc (AIM:ULT) provider of interactive health care services announced that seven Primary Care Trusts (PCTs) in the East Midlands have contracted to provide ‘Beating the Blues’ (a computerised form of Cognitive Behavioural Therapy) to all their patients with mild to moderate depression.
The agreement is a significant breakthrough for Ultrasis, the two-year agreement has an initial value of more than £450,000. It will enable the PCTs involved to be at least 25% compliant with the implementation requirements of The National Institute for Health and Clinical Excellence (NICE).
Nigel Brabbins, Chief Executive of Ultrasis, said:
"In March 2007 Patricia Hewitt, then Health Secretary, promised to make ‘Beating the Blues’ available nationally to any patient who needs it. We are actively campaigning to encourage the recently appointed Secretary of State for Health, Alan Johnson, to implement the NICE guidance."
Shares in Ultrasis rose 21% to 1.08p on the news.
View full ULT profile
December 11 2014
January 29 2016
A return to Nasdaq and ongoing commercial success promises to address a significant disconnect in the valuation of Pressure Bioscience...
March 31 2016
Amryt Pharmaceuticals will join the London market in a deal that values it at £29.6mln. A share placing, meanwhile, will bring in £10mln to be used to develop the company’s lead treatment for a rare skin disorder.
April 28 2016
Last year's acquisition of Kinesis Pharma meant that it could now offer a one-stop shop for its pharmaceuticals clients and expand its client base.